Clinical Trials in Atlanta

Showing 2461-2480 of 19,805 trials

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

NCT07061938

ACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy derived from healthy donors, that is under investigation for the treatment in subjects with Immunoglobulin G4 Related Disease (IgG4-RD)

IgG4 Related Disease

Acepodia Biotech, Inc.30 participantsStarted Jan 2026

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Kahoku-gun, JP, Japan

RECRUITINGPhase 3< 1 mile

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

NCT07104383

This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight

Weight Loss

Viking Therapeutics, Inc.1,100 participantsStarted Jun 2025

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +131 more locations

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Find Trials by Condition in Atlanta

Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Compassionate Use of Concizumab if You Have Haemophilia

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

Role of Prophylactic Postoperative Antibiotics in HoLEP

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment